Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Biotechnology
US cell and gene therapy company Abeona Therapeutics saw its shares gain 4.2% to $3.75 in after-hours trading Tuesday, after it announced that the European Medicines Agency has granted the designation of Priority Medicines ( PRIME) for its ABO-102, which studies its punctual gene therapy based on adeno-associated virus 9 (AAV9) for the treatment of Sanfilippo syndrome type A (MPS IIIA). 27 December 2019
Pharmaceutical
The life sciences sector is in the news again in India and has entered the top league. The pharmaceuticals and healthcare sector recorded the second highest value of private equity and venture capital investments in November at $1.2 billion. This also happens to be the sector’s highest-ever value of private equity investment in a month, signalling the trajectory of the Indian life sciences industry, reports The Pharma Letter’s India correspondent. 17 December 2019
Biotechnology
Switzerland-based biotech Numab have formed a partnership focusing on the development and commercialization of a portfolio of novel multi-specific antibodies for the therapy of cancer based on Numab’s technology platform with 3Sbio subsidiary Sunshine Guojian Pharmaceutical. 12 December 2019
Biotechnology
French biotech ImCheck Therapeutics has raised $53 million in a Series B financing to advance its clinical pipeline of gamma delta T-cell-focused antibodies for cancer and autoimmune diseases. 4 December 2019
Biotechnology
Cambridge Innovation Capital (CIC), the UK venture capital investor enabling visionaries to build global, category-leading companies in the Cambridge ecosystem, has provided an update on its performance for the six months ended September 30, 2019, showing it has attracted £1 billion ($1.29 billion) of investments into Cambridge companies. 2 December 2019
Pharmaceutical
French company MedinCell and the Bill & Melinda Gates Foundation have signed an agreement for up to an additional $19 million to be granted over four years. It aims to fund pre-clinical activities and a Phase I clinical trial for the injectable six-month bioresorbable contraceptive (mdc-WWM). 29 November 2019
Biotechnology
Immunitas Therapeutics, a single cell genomics-based drug discovery company founded by Longwood Fund, today announced a $39 million Series A financing led by Leaps by Bayer and Novartis Venture Fund and joined by additional investors including Evotec, M Ventures, Alexandria Venture Investments, and other institutional investors. 21 November 2019
Biotechnology
UK-based company Healx has launched its Rare Treatment Accelerator (RTA). 21 November 2019
Biotechnology
Fujifilm Diosynth Biotechnologies (FDB), a leading global biologics Contract Development and Manufacturing Organization (CDMO) has announced the expansion of its gene therapy services with the addition of dedicated process and analytical development laboratories. 15 November 2019
Biotechnology
A new company has spun out of the UK’s University of Leeds with the stated aim of developing advanced anticoagulants with minimal bleeding risk. 14 November 2019
Biotechnology
A new London-based cancer vaccine and immunotherapy company, Ervaxx, has launched following two years in incubation. 6 November 2019
Biosimilars
Icelandic biosimilars specialist Alvotech has sold a 2.5% stake to Abu Dhabi-based investment company, Yas Holding. 5 November 2019
Biosimilars
The European Investment Bank (EIB) has agreed to lend 30 million euros ($33.4 million) to Mabion, a Polish biotech company, to finance its growth plans. 24 October 2019
Biotechnology
In March 2019, after a series of political convolutions worthy of a Choose Your Own Adventure novel, former UK Prime Minister Theresa May finally managed to bring her country, and its complaining industries, to the brink of Brexit. 23 October 2019
Biotechnology
French firm Alaxia, an affiliate of the Stragen Healthcare Group developing therapeutic solutions for respiratory diseases, has joined the inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis (iABC) consortium as a partner. 23 October 2019
Pharmaceutical
German Science and pharma company Merck KGaA today announced a 100 million renminbi ($13.5 million) seed fund targeted at start-ups in China. 18 October 2019
Biotechnology
Shares of Israel’s RedHill Biopharma leapt 10% pre-market and were still up 5% at $6.48 inn late morning US trading after the company announced an exclusive license agreement with Cosmo Pharmaceuticals for US rights to Aemcolo (rifamycin) for traveler’s diarrhea and a simultaneous private investment by Cosmo. 17 October 2019
Biotechnology
Privately-held UK biotech GammaDelta Therapeutics, a firm focussed on harnessing the unique properties of gamma delta T-cells to develop immunotherapies, has announced the formation of a spin-out company. 16 October 2019
Biotechnology
Czech investor the PPF Group and the affiliated biotech company SOTIO have announced a deal with Maverix Oncology, a private company with a proprietary pipeline of targeted, small molecule cancer chemo-immunotherapeutics. 15 October 2019
Biotechnology
UK-based biotech firm Prokarium says it has received an investment of £4.59 million ($5.6 million) from the Wellcome Trust to fund two clinical trials of its lead program, Entervax, a bivalent vaccine against enteric fever. 9 October 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze